I stand by my statement from many months ago that on the
I stand by my statement from many months ago that on the Ihub "depends" board there are well less than 1m shares aggregate and thats being very generous. So the impact of that forum is even less than Ironridge's 1.6m shares.
Here is what I believe. In my humble opinion I am of the belief that Seaside is already 50% done I will guess 2.5m shares left and thats it. I believe BKRT,BHMM, and Bmak are comprised of Seaside. So add Ironridge to the equation 1.6m thats no more than 4.1m shares which is the most. Of the 24m shares at .05 probably quite a few have been flushed out and the rest I believe will hold for far greater levels.
Bottom line: We have done 7m shares the last 9 days at average price .12 approx 840k dollars have been traded, so we cleaned up a lot of paper. My best guess is at the most we have 7m shares to go thru which is supply that will ultimately be taken care of well within 6-9 months. It could be as short as 8 weeks or less if we get catalysts that move the stock.
This is the least amount of supply we have had on the books in a long time. I believe the core holders will not be sellers here the majority anyway. So when we contend with 4.1m shares from Seaside and Ir ( including IR) we are DONE WITH ANY OUTSIDE ENTITY.
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...
Continue Reading
Mac Cummings: A Maverick at Terakeet's Helm So, here’s the deal—we’ve got Mac Cummings, a guy who's shaking up the marketing world just when we thought we had it all figured out. When you get a nod from ADWEEK's Innovator 50, it isn't because you played it safe. It's because you believed in disrupting the status quo. Cummings has taken Terakeet from a humble start...
Continue Reading
The Surging Demand for Tea Extracts The tea extract market's carving out quite a niche for itself. From $3.22 billion in 2026, it's primed to scale up to a cool $4.70 billion by 2031. That's a steady 7.9% growth rate, and it's just fueled by the booming demand for all things natural and health-oriented. Natural and Functional: Key Industry Drivers Consumers these days...
Continue Reading
China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...
Continue Reading
Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...
Continue Reading
Omnissa Rolls Out AI Sovereignty Across New Markets In the world of AI, where data is king and control is the crown, Omnissa is making bold moves with its latest expansion announcement. The company's Sovereign Solution (OSS) is now reaching into six fresh markets across Europe and Asia, offering organizations a vital grip on their digital domains like never before. Talk...
Continue Reading
Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...
Continue Reading
Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...
Continue Reading
A Young Racer's Roaring Start Every once in a while, a kid shows up on the scene who just makes you sit up and pay attention. Enter Zayne Burgess, a mere 10-year-old with the skill set of a seasoned pro. If you care about the future of racing, you better start watching this young'un, because he's chasing a Formula 1 dream and has K1 Speed putting their chips on him....
Continue Reading
A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Recent Insider Transactions at Tanger Inc. A noteworthy insider sell has surfaced recently, involving Joseph Thomas Guerrieri JR, who serves as Senior Vice President at Tanger (NYSE: SKT). The details of this transaction arose from a recent filing with the SEC, highlighting a substantial move by an insider. Transaction Overview: JR opted to divest 3,000...
Continue Reading
The Remarkable Growth of Charles Schwab Stock Over the past 20 years, Charles Schwab has consistently outperformed the overall market, showcasing a remarkable annualized return of 10.34%. This impressive performance has led to a market capitalization of approximately $141.73 billion. Understanding how this growth can translate for individual investors can provide valuable...
Continue Reading
Exciting New Community Opening in Tolleson Richmond American Homes is thrilled to announce the grand opening of the Seasons at Vista Del Sur community. This new development promises to be a welcoming place for families and individuals looking to settle in a vibrant environment. With an impressive range of single- and two-story homes, Richmond American is committed to...
Continue Reading
Rocket Lab Chosen for Groundbreaking NASA Mars Study Rocket Lab USA, Inc. (NASDAQ: RKLB) has an exciting opportunity in store as it embarks on a study for NASA's Mars Sample Return Program. This initiative is poised to be a historic endeavor, aiming to retrieve Martian rock samples and analyze them on Earth—offering unprecedented insights into Mars and the potential for...
Continue Reading
A Robust Quarter for ASE Technology Alright, sit down and buckle up because ASE Technology (NYSE: ASX) just dropped some eye-popping numbers for Q2 2026. This isn't some mild market fluctuation—this is what you call a serious win in the semiconductor game. With net revenues soaring to NT$191,064 million, it’s about 26.7% up from the same quarter last year. Now, that's...
Continue Reading